Other News

Protaryx Medical Announces $8.3M in Funding for First-in-Class Technology for Left Atrial Access in Transcatheter Cardiac Procedures

$5.1M Series A Funding Led by Ajax Health Will Be Used to Develop First-in-Class Product Designed with Three-Dimensional, Independent Steerability to Deliver Reliable Access June 30, 2020 08:00 AM Eastern Daylight Time BALTIMORE–(BUSINESS WIRE)–Protaryx™ Medical, a company committed to reimagining access to the left atrium for transcatheter cardiac procedures, today […]

BioSig Technologies, Inc Closes $17.5 Million Common Stock Offering

Westport, CT, June 29, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its majority-owned subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it has closed on the sale of 2,187,500 shares of the Company’s common stock, at a purchase price of $8.00 per share, in a registered […]

Intact Vascular Announces Positive One-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

Durable Below-the-Knee Vascular Implant for Post-Angioplasty Dissection Repair Demonstrates Sustained Success Saving Limbs WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the positive one-year results from its Tack Optimized Balloon Angioplasty (TOBA) II BTK clinical trial during the 2020 Vascular Interventional Advances (VIVA) Late-Breaking Clinical […]

New SEMI-NBMC, GE Research Project to Advance Vital Signs Monitoring of Patients During Emergency Air Transport

MILPITAS, Calif., June 22, 2020 /PRNewswire/ — Nano-Bio Materials Consortium (NBMC), a SEMI Strategic Association Partner, today launched a project with GE Research to develop a medical-grade wireless patch that monitors the vital signs of medical patients during emergency air transport. The device promises to advance the state-of-the-art in medical care […]

New Research Finds Abbott’s Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages

— Using optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI), physicians were able to select the right size stents and place them with greater precision — Imaging techniques such as OCT have been shown to improve outcomes during stenting procedures¹, but remain underutilized in global clinical settings due to lack […]

Maxim Integrated Highlights Ways to Enhance Reliability of PPG Data for Health-Monitoring Wearables

SAN JOSE, Calif., June 26, 2020 /PRNewswire/ — Whether a sensor can provide reliable data depends on the target information, the algorithm deployed, and the specific details of a given use case. Optical biosensing has become a mainstream feature in smart watches and fitness wearables, providing actionable insights to support preventative healthcare, […]

Neovasc Announces Positive Interim Results from REDUCER-I Study

VANCOUVER and MINNEAPOLIS, June 26, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today announced positive interim results of the REDUCER-I study during the PCR E-Course. Stefan Verheye, MD, PhD, ZNA Middelheim, Antwerp, Belgium presented the results of the trial during the Hotline and Innovation […]

New data reconfirms long-term safety profile of the Philips Stellarex low-dose Drug-Coated Balloon

June 26, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the four-year results from the ILLUMENATE European Randomized Controlled Trial (EU RCT). The Stellarex DCB cohort demonstrated similar all-cause mortality compared with the control arm through four years. This analysis included […]

JanOne taps distinguished chemist Dr. Doug Flanagan as chief formulation advisor

Dr. Flanagan, an accomplished chemist and formulation specialist, leads manufacturing and clinical development of JanOne’s PAD candidate TV1001SR LAS VEGAS, June 25, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, continues to build […]